Coronary artery disease may rarely be due to vasculitis. Angina pectoris and acute myocardial infarction have been reported in patients with Takayasu's disease, polyarteritis nodosa, and thromboangiitis obliterans. TM In this article we report a case of Buerger's disease localized to coronary and internal thoracic arteries (ITAs) in a young nonsmoking woman. The diagnosis was made by histologic examination of the ITAs that were discarded at the time of bypass surgery.
emic heart disease. She had never smoked. She never had aphthous ulcerations in the mouth or genitalia, nor had she a history of bronchial asthma, rash. fever, myalgia, or arthralgia. Routine blood assays were all within normal limits with the exception of the erythrocyte sedimentation rate (35 mm/hr). Because of unstable angina, the patient underwent cardiac catheterization, which showed severe left main disease ( Fig. 1 . A I and critical stenoses of the right coronary artery (Fig. 1, B) necessitating urgent myocardial revascularization. After a standard median sternotomy, both ITAs were dissected but were found to be unsuitable for grafting because of diffuse narrowing at the proximal end and occlusion at the distal end. Moreover. satellite lymph nodes were enlarged. Three coronary arteries were bypassed with saphenous veins: the left anterior descending artery and the first obtuse marginal branch had a small caliber (<1.5 mm), and the posterior descending artery was thickened. The postoperative course was uneventful.
Vascular specimens were examined histologically. The ITAs showed occlusion of the lumen owing to fibrous hyaline tissue with evidence of neovascularity, in keeping with an organized thrombus, with an intact internal elastic membrane and tunica media (Fig. 2, A) . The vein specimen showed intimal clusters of granulocytes with superimposed mural thrombosis (Fig. 2. B) . The artery and the veto were surrounded by fat with signs of periadventitial fibrosis involving neural structures and by lymph nodes with follicular hyperplasia. The diagnosis was consistent with thromboangiitis obliterans. Anti-core, anti-mitochondrial, anti-smooth muscle, anti-cardiolipin, anti-ribosome, and anti-reticulin antibodies and rheumatoid factor were not detected. Measurements of C3 and C4 in the blood, as well as nephroscintigraphy, were within normal limits.
At 8 months' follow-up the patient was doing well and was free of recurrent angina. Blood assays were within normal ranges with the exception of an elevated concentration of serum lipoprotein(a) (36.1 mg/dl with a cutoff of 20 mg/dl).
Buerger's disease may involve vessels other than those of the extremities. 5 Acute myocardial infarction owing to involvement of epicardial coronary arteries has been reported to be prevalent in affected patients. 6 However, so far as we know, this is the first case of solitary localization of thromboangiitis obliterans in the chest involving both coronary arteries and ITAs. The diagnosis was made by histologic examination of ITAs discarded at operation, which showed thrombotic occlusion and intimal abscesses with an intact internal elastic lamina and tunica media. Before the operation, the diagnosis of Buerger's disease in this nonsmoking woman was unsuspected, because women are rarely affected by Buerger's disease 7 and smoking is considered a major cause. However, histologic features were pathognomonic and other types of vasculitis (Behcet's disease, polyarteritis nodosa, Kawasaki's syndrome, vasculitis in systemic lupus erythematosus and rheumatoid arthritis, Churg-Strauss disease, Takayasu's arteritis, and Wegener's granulomatosis) were excluded by clinical history, blood assays, and histologic studies.
Thromboangiitis obliterans is a nonatherosclerotic inflammatory occlusive vascular disease of unknown origin. In the absence of smoking, other risk factors, such as serum lipoprotein(a), must be considered in the pathogenesis of this disease. 8 Even though 8 months after the operation the patient had returned to her normal activities, the prognosis will be influenced by the potential, and previously reported occurrence of thromboangiitis obliterans in the aorta-coronary saphenous vein grafts. 9 blood during hemostasis after CPB, we gave an additional half of the pre-CPB dose of TA during the post-CPB period. The objective of this study was to investigate whether an additional postbypass dose of TA affects post-CPB blood loss after cardiac operations.
Methods. Ninety-three patients undergoing either coronary artery bypass grafting or heart valve operation were studied with their informed consent. Approval for the study was received from our hospital's ethics review board. Only one cardiac surgeon (K. T.) was involved in the study. In this prospective, randomized trial, the patients were divided into three groups of equal size. Patient characteristics are summarized in Table I .
All patients received high-dose fentawl anesthesia. Before CPB was established, heparin. 200 IU/kg, was given intravenously to each patient. Additional heparin was added throughout CPB to maintain the activated clotting time at more than 400 seconds. Heparin was neutralized with protamine sulfate with the use of dose-response curves. Group TA-1 patients received an infusion of TA. 100 mg/kg, intravenously, over 20 minutes soon after induction of anesthesia and before CPB. Group TA-2 patients received a 100 mg/kg dose of TA. like the group TA-1 patients, and an additional TA dose of 50 mg/kg infused intravenously over 20 minutes soon after being weaned from CPB. Control group patients received conventional perioperative therapy. Red blood cells (RBCs) were transfused for a hemoglobin threshold of 75 gm/L or less. Mediastinal blood loss during the operation, but after discontinuation of CPB. and drain-
